• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻素 CB2 受体功能变异(Q63R)与伊朗人群中的多发性硬化症有关。

Cannabinoid CB2 Receptor Functional Variation (Q63R) Is Associated with Multiple Sclerosis in Iranian Subjects.

机构信息

Neuroscience Research Center, Golestan University of Medical Sciences, Gorgan, Iran.

Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.

出版信息

J Mol Neurosci. 2020 Jan;70(1):26-31. doi: 10.1007/s12031-019-01395-9. Epub 2019 Aug 13.

DOI:10.1007/s12031-019-01395-9
PMID:31407233
Abstract

The cannabinoid system has been identified as a critical endogenous regulator of immune homeostasis through immunomodulatory actions. This system is one of the main regulatory systems of the central nervous system (CNS). Variations in the cannabinoid CB2 receptor gene (CNR2) could affect intracellular signaling and reduce system function, which has been associated with an unbalanced immune response and increased risk of a variety of autoimmune inflammatory disorders. The present study investigated the relationship between CNR2 rs35761398 (Q63R) functional variation and multiple sclerosis (MS). A total of 100 Iranian MS patients and 100 healthy controls were enrolled in the study and genotyped through TaqMan assay. The co-dominant, dominant, recessive, over-dominant, and additive inheritance models were analyzed using SNPStats software. A significant genetic association was observed between Q63R polymorphism and MS. The dominant model was accepted as the best inheritance model to fit the data (OR 2.70, 95% CI 1.47-4.97, p = 0.001). The data implied the involvement of the CNR2 gene in susceptibility to MS in Iranian patients.

摘要

大麻素系统已被确定为通过免疫调节作用对免疫稳态的关键内源性调节剂。该系统是中枢神经系统 (CNS) 的主要调节系统之一。大麻素 CB2 受体基因 (CNR2) 的变异可能会影响细胞内信号转导并降低系统功能,这与不平衡的免疫反应和增加多种自身免疫性炎症性疾病的风险有关。本研究探讨了 CNR2 rs35761398 (Q63R) 功能变异与多发性硬化症 (MS) 之间的关系。本研究共纳入 100 名伊朗 MS 患者和 100 名健康对照者,并通过 TaqMan 分析进行基因分型。使用 SNPStats 软件分析了共显性、显性、隐性、过显性和加性遗传模型。Q63R 多态性与 MS 之间存在显著的遗传关联。显性模型被接受为拟合数据的最佳遗传模型 (OR 2.70, 95% CI 1.47-4.97, p = 0.001)。数据表明 CNR2 基因参与了伊朗患者 MS 的易感性。

相似文献

1
Cannabinoid CB2 Receptor Functional Variation (Q63R) Is Associated with Multiple Sclerosis in Iranian Subjects.大麻素 CB2 受体功能变异(Q63R)与伊朗人群中的多发性硬化症有关。
J Mol Neurosci. 2020 Jan;70(1):26-31. doi: 10.1007/s12031-019-01395-9. Epub 2019 Aug 13.
2
Functional variation (Q63R) in the cannabinoid CB2 receptor may affect the severity of COVID-19: a human study and molecular docking.大麻素CB2受体的功能变异(Q63R)可能会影响COVID-19的严重程度:一项人体研究及分子对接
Arch Virol. 2021 Nov;166(11):3117-3126. doi: 10.1007/s00705-021-05223-7. Epub 2021 Sep 13.
3
The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention.大麻素受体 2 型 Q63R 变体增加了乳糜泻的风险:对新型分子生物标志物和未来治疗干预的启示。
Pharmacol Res. 2012 Jul;66(1):88-94. doi: 10.1016/j.phrs.2012.03.011. Epub 2012 Mar 24.
4
No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects.土耳其人群中功能性大麻素2型受体Q63R变体与炎症性肠病之间无关联。
Turk J Gastroenterol. 2014 Dec;25(6):639-43. doi: 10.5152/tjg.2014.6568.
5
Study of cannabinoid receptor 2 Q63R gene polymorphism in Lebanese patients with rheumatoid arthritis.黎巴嫩类风湿关节炎患者大麻素受体 2 Q63R 基因多态性研究。
Clin Rheumatol. 2018 Nov;37(11):2933-2938. doi: 10.1007/s10067-018-4217-9. Epub 2018 Jul 21.
6
Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic childhood immune thrombocytopenia in Egypt.大麻素CB2受体基因(CNR2)多态性与埃及儿童慢性免疫性血小板减少症相关。
Blood Coagul Fibrinolysis. 2013 Apr;24(3):247-51. doi: 10.1097/MBC.0b013e32835aba1d.
7
The Cannabinoid Receptor 2 Q63R Variant Modulates the Relationship between Childhood Obesity and Age at Menarche.大麻素受体2 Q63R变体调节儿童肥胖与初潮年龄之间的关系。
PLoS One. 2015 Oct 8;10(10):e0140142. doi: 10.1371/journal.pone.0140142. eCollection 2015.
8
Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C.大麻素受体 2 多态性与慢性丙型肝炎患者严重坏死性炎症的关联。
Clin Gastroenterol Hepatol. 2014 Feb;12(2):334-40. doi: 10.1016/j.cgh.2013.05.008. Epub 2013 May 22.
9
Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis.2型大麻素受体Q63R变体与少关节/多关节型幼年特发性关节炎之间的关联
Scand J Rheumatol. 2015;44(4):284-7. doi: 10.3109/03009742.2015.1020863. Epub 2015 May 14.
10
Role of Cannabinoid CB2 Receptor Gene (CNR2) Polymorphism in Children with Immune Thrombocytopenic Purpura in Beni-Suef Governorate in Egypt.大麻素CB2受体基因(CNR2)多态性在埃及贝尼苏韦夫省免疫性血小板减少症儿童中的作用。
Egypt J Immunol. 2017 Jan;24(1):57-66.

引用本文的文献

1
Association of Cannabinoid CB2 Receptor Q63R Variant With Rheumatoid Arthritis in an Iranian Cohort.伊朗人群队列中大麻素CB2受体Q63R变异与类风湿关节炎的关联
Int J Genomics. 2025 Jun 16;2025:6182868. doi: 10.1155/ijog/6182868. eCollection 2025.
2
The endocannabinoid system's genetic polymorphisms in sickle cell anemia patients.镰状细胞贫血患者体内内源性大麻素系统的基因多态性。
Sci Rep. 2024 Dec 30;14(1):31562. doi: 10.1038/s41598-024-76480-0.
3
Cannabinoid Receptor 2 Gene Polymorphism and the Risk of Developing Rheumatoid Arthritis in Lebanese Patients.

本文引用的文献

1
Disease severity in respiratory syncytial virus infection: Role of host genetic variation.呼吸道合胞病毒感染的疾病严重程度:宿主遗传变异的作用。
Rev Med Virol. 2019 Mar;29(2):e2026. doi: 10.1002/rmv.2026. Epub 2019 Jan 4.
2
Study of cannabinoid receptor 2 Q63R gene polymorphism in Lebanese patients with rheumatoid arthritis.黎巴嫩类风湿关节炎患者大麻素受体 2 Q63R 基因多态性研究。
Clin Rheumatol. 2018 Nov;37(11):2933-2938. doi: 10.1007/s10067-018-4217-9. Epub 2018 Jul 21.
3
Multiple Sclerosis.多发性硬化症
大麻素受体2基因多态性与黎巴嫩患者患类风湿关节炎的风险
Cannabis Cannabinoid Res. 2024 Dec;9(6):e1597-e1603. doi: 10.1089/can.2023.0220. Epub 2024 Mar 18.
4
Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential.神经退行性蛋白病中的大麻素CB2受体:新见解与治疗潜力
Biomedicines. 2022 Nov 22;10(12):3000. doi: 10.3390/biomedicines10123000.
5
Endocannabinoid signaling in the central nervous system.中枢神经系统中的内源性大麻素信号传导。
Glia. 2023 Jan;71(1):5-35. doi: 10.1002/glia.24280. Epub 2022 Oct 29.
6
Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders.精神疾病中环核苷酸系统的分子改变。
Int J Mol Sci. 2022 Apr 26;23(9):4764. doi: 10.3390/ijms23094764.
7
New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders.中枢神经系统疾病中 CB2 大麻素受体的新见解和潜在治疗靶点。
Int J Mol Sci. 2022 Jan 17;23(2):975. doi: 10.3390/ijms23020975.
8
Functional variation (Q63R) in the cannabinoid CB2 receptor may affect the severity of COVID-19: a human study and molecular docking.大麻素CB2受体的功能变异(Q63R)可能会影响COVID-19的严重程度:一项人体研究及分子对接
Arch Virol. 2021 Nov;166(11):3117-3126. doi: 10.1007/s00705-021-05223-7. Epub 2021 Sep 13.
9
Biased Coupling to β-Arrestin of Two Common Variants of the CB Cannabinoid Receptor.两种常见大麻素 CB 受体变体与β-arrestin 的偏向性耦联。
Front Endocrinol (Lausanne). 2021 Aug 16;12:714561. doi: 10.3389/fendo.2021.714561. eCollection 2021.
Semin Neurol. 2018 Apr;38(2):212-225. doi: 10.1055/s-0038-1649502. Epub 2018 May 23.
4
Genetic Variant Q63R of Cannabinoid Receptor 2 Causes Differential ERK Phosphorylation in Human Immune Cells.大麻素受体2的基因变体Q63R在人类免疫细胞中导致不同的细胞外信号调节激酶磷酸化。
Genet Test Mol Biomarkers. 2018 May;22(5):320-326. doi: 10.1089/gtmb.2018.0005. Epub 2018 Apr 25.
5
Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice.大麻素受体 2 在人类和小鼠呼吸道合胞病毒感染中的作用。
Virulence. 2018 Jan 1;9(1):217-230. doi: 10.1080/21505594.2017.1389369. Epub 2017 Dec 8.
6
The genetics of multiple sclerosis in Latin America.拉丁美洲多发性硬化症的遗传学
Mult Scler J Exp Transl Clin. 2017 Sep 25;3(3):2055217317727295. doi: 10.1177/2055217317727295. eCollection 2017 Jul-Sep.
7
Endocannabinoids and Immunity.内源性大麻素与免疫
Cannabis Cannabinoid Res. 2016 Feb 1;1(1):59-66. doi: 10.1089/can.2016.0002. eCollection 2016.
8
Multiple sclerosis: Pathology, diagnosis and treatments.多发性硬化症:病理学、诊断与治疗
Exp Ther Med. 2017 Jun;13(6):3163-3166. doi: 10.3892/etm.2017.4410. Epub 2017 Apr 28.
9
Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease.大麻素受体2功能变体增加儿童炎症性肠病风险。
J Clin Gastroenterol. 2018 May/Jun;52(5):e37-e43. doi: 10.1097/MCG.0000000000000755.
10
Epidemiology of Multiple Sclerosis.多发性硬化症的流行病学
Neurol Clin. 2016 Nov;34(4):919-939. doi: 10.1016/j.ncl.2016.06.016. Epub 2016 Aug 18.